Cardlytics Inc
NASDAQ:CDLX

Watchlist Manager
Cardlytics Inc Logo
Cardlytics Inc
NASDAQ:CDLX
Watchlist
Price: 3.71 USD 4.51% Market Closed
Market Cap: 188.5m USD
Have any thoughts about
Cardlytics Inc?
Write Note

Intrinsic Value

The intrinsic value of one CDLX stock under the Base Case scenario is 4.85 USD. Compared to the current market price of 3.71 USD, Cardlytics Inc is Undervalued by 23%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CDLX Intrinsic Value
4.85 USD
Undervaluation 23%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Cardlytics Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
CDLX
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for CDLX cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about CDLX?
Bearish
Neutral
Bullish

Fundamental Analysis

3.71 USD
+4.51%
+4.51%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Cardlytics Inc
US
Media
Market Cap
186.8m USD
IPO
Feb 9, 2018
Employees
591
United States of America
Market Cap
186.8m USD
Industry
Media
IPO
Feb 9, 2018
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Cardlytics Inc

Provide an overview of the primary business activities
of Cardlytics Inc.

What unique competitive advantages
does Cardlytics Inc hold over its rivals?

What risks and challenges
does Cardlytics Inc face in the near future?

Has there been any significant insider trading activity
in Cardlytics Inc recently?

Summarize the latest earnings call
of Cardlytics Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Cardlytics Inc.

Provide P/S
for Cardlytics Inc.

Provide P/E
for Cardlytics Inc.

Provide P/OCF
for Cardlytics Inc.

Provide P/FCFE
for Cardlytics Inc.

Provide P/B
for Cardlytics Inc.

Provide EV/S
for Cardlytics Inc.

Provide EV/GP
for Cardlytics Inc.

Provide EV/EBITDA
for Cardlytics Inc.

Provide EV/EBIT
for Cardlytics Inc.

Provide EV/OCF
for Cardlytics Inc.

Provide EV/FCFF
for Cardlytics Inc.

Provide EV/IC
for Cardlytics Inc.

Show me price targets
for Cardlytics Inc made by professional analysts.

What are the Revenue projections
for Cardlytics Inc?

How accurate were the past Revenue estimates
for Cardlytics Inc?

What are the Net Income projections
for Cardlytics Inc?

How accurate were the past Net Income estimates
for Cardlytics Inc?

What are the EPS projections
for Cardlytics Inc?

How accurate were the past EPS estimates
for Cardlytics Inc?

What are the EBIT projections
for Cardlytics Inc?

How accurate were the past EBIT estimates
for Cardlytics Inc?

Compare the revenue forecasts
for Cardlytics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Cardlytics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Cardlytics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Cardlytics Inc compared to its peers.

Compare the P/E ratios
of Cardlytics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Cardlytics Inc with its peers.

Analyze the financial leverage
of Cardlytics Inc compared to its main competitors.

Show all profitability ratios
for Cardlytics Inc.

Provide ROE
for Cardlytics Inc.

Provide ROA
for Cardlytics Inc.

Provide ROIC
for Cardlytics Inc.

Provide ROCE
for Cardlytics Inc.

Provide Gross Margin
for Cardlytics Inc.

Provide Operating Margin
for Cardlytics Inc.

Provide Net Margin
for Cardlytics Inc.

Provide FCF Margin
for Cardlytics Inc.

Show all solvency ratios
for Cardlytics Inc.

Provide D/E Ratio
for Cardlytics Inc.

Provide D/A Ratio
for Cardlytics Inc.

Provide Interest Coverage Ratio
for Cardlytics Inc.

Provide Altman Z-Score Ratio
for Cardlytics Inc.

Provide Quick Ratio
for Cardlytics Inc.

Provide Current Ratio
for Cardlytics Inc.

Provide Cash Ratio
for Cardlytics Inc.

What is the historical Revenue growth
over the last 5 years for Cardlytics Inc?

What is the historical Net Income growth
over the last 5 years for Cardlytics Inc?

What is the current Free Cash Flow
of Cardlytics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Cardlytics Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cardlytics Inc

Current Assets 183.3m
Cash & Short-Term Investments 67m
Receivables 109.6m
Other Current Assets 6.8m
Non-Current Assets 216.1m
PP&E 9.8m
Intangibles 204.1m
Other Non-Current Assets 2.2m
Current Liabilities 155.9m
Accounts Payable 3.9m
Accrued Liabilities 19m
Short-Term Debt 45.8m
Other Current Liabilities 87.2m
Non-Current Liabilities 173.8m
Long-Term Debt 167.4m
Other Non-Current Liabilities 6.3m
Efficiency

Earnings Waterfall
Cardlytics Inc

Revenue
293.5m USD
Cost of Revenue
-136.4m USD
Gross Profit
157.1m USD
Operating Expenses
-238.6m USD
Operating Income
-81.4m USD
Other Expenses
-193.1m USD
Net Income
-274.6m USD

Free Cash Flow Analysis
Cardlytics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

CDLX Profitability Score
Profitability Due Diligence

Cardlytics Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Negative 1-Year Revenue Growth
Declining ROIC
23/100
Profitability
Score

Cardlytics Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

CDLX Solvency Score
Solvency Due Diligence

Cardlytics Inc's solvency score is 22/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Short-Term Solvency
Positive Net Debt
High D/E
22/100
Solvency
Score

Cardlytics Inc's solvency score is 22/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CDLX Price Targets Summary
Cardlytics Inc

Wall Street analysts forecast CDLX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CDLX is 4.49 USD with a low forecast of 4.04 USD and a high forecast of 5.25 USD.

Lowest
Price Target
4.04 USD
9% Upside
Average
Price Target
4.49 USD
21% Upside
Highest
Price Target
5.25 USD
42% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CDLX?

Click here to dive deeper.

Dividends

Cardlytics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CDLX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

CDLX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one CDLX stock?

The intrinsic value of one CDLX stock under the Base Case scenario is 4.85 USD.

Is CDLX stock undervalued or overvalued?

Compared to the current market price of 3.71 USD, Cardlytics Inc is Undervalued by 23%.

Back to Top